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Abstract. Insulin stimulates glucose transport in adipo- 
cytes by translocation of the glucose transporter 
(GLUT-4) from an intracellular site to the cell surface. 
We have characterized different synaptobrevin/vesicle- 
associated membrane protein (VAMP) homologues in 
adipocytes and studied their intracellular distribution 
with respect to GLUT-4. VAMP-l, VAMP-2, and cel- 
lubrevin cDNAs were isolated from a 3T3-L1 adipocyte 
expression library. VAMP-2 and cellubrevin were: (a) 
the most abundant isoforms in adipocytes, (b) detect- 
able in all insulin responsive tissues, (c) translocated to 
the cell surface in response to insulin, and (d) found in 
immunoadsorbed GLUT-4 vesicles. To further define 
their intracellular distribution, 3T3-L1 adipocytes were 
incubated with a transferrin/HRP conjugate (Tf/HRP) 
and endosomes ablated following addition of DAB and 
H202. While this resulted in ablation of >90% of the 
transferrin receptor (TfR) and cellubrevin found in in- 
tracellular membranes, 60% of GLUT-4 and 90% of 
VAMP-2 was not ablated. Immuno-EM on intracellular 
vesicles from adipocytes revealed that VAMP-2 was 
colocalized with GLUT-4, whereas only partial colocal- 
ization was observed between GLUT-4 and cellubre- 
vin. These studies show that two different v-SNAREs, 
cellubrevin and VAMP-2, are partially segregated in 
different intracellular compartments in adipocytes, im- 
plying that they may define separate classes of secre- 
tory vesicles in these cells. We conclude that a propor- 
tion of GLUT-4 is found in recycling endosomes in 
nonstimulated adipocytes together with cellubrevin and 
the transferrin receptor. In addition, GLUT-4 and 
VAMP-2 are selectively enriched in a postendocytic 
compartment. Further study is required to elucidate the 
function of this latter compartment in insulin-respon- 
sive cells. 
I 
NSULIN stimulates glucose transport in muscle  and 
adipose tissue  by provoking the translocation of glu- 
cose  transporters,  specifically  glucose  transporter-4 
(GLUT-4),  t from an intracellular vesicular pool to the cell 
surface (Cushman and Wardzala, 1980; Suzuki and Kono, 
1980). Despite considerable progress in our understanding 
of this process, a number of major questions remain. What 
is  the nature of the intracellular GLUT-4 compartment 
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and is it present in all cells? Is this compartment of endo- 
somal origin  or is it analogous to  a  secretory compart- 
ment? What other proteins are located in this compart- 
ment and how does GLUT-4 move from this site to the 
cell surface? The soluble N-ethyl maleimide-sensitive  fac- 
tor attachment protein receptor (SNARE) hypothesis pro- 
vides an avenue for addressing such questions. Vesicles in- 
teract with their target membranes via the binding of 
v-  and t-SNAREs  (Sollner  et al.,  1993). The specificity 
that  is  required  to  regulate  the  myriad of intracellular 
transport reactions is seemingly provided by different 
v- and t-SNARE isoforms. For instance, v- and t-SNAREs 
that  regulate  endoplasmic  reticulum to  Golgi  transport 
(Bennett and Scheller, 1993), intra-Golgi transport (Ban- 
field et al., 1995), and Golgi to plasma membrane traffic 
(Bennett and Scheller,  1993) have all been identified in 
yeast. Vesicle-associated  membrane protein (VAMP)/syn- 
aptobrevin is a mammalian homologue of the yeast v-SNAREs. 
VAMP was first identified in brain (Trimble et al., 1988; 
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the fusion of small synaptic vesicles (SSVs) with the pre- 
synaptic plasma membrane (Schiavo et al., 1992; Stidhof et 
al., 1993).  More recently, VAMP has also been identified 
in adipocytes (Cain et al., 1992). This raises the possibility 
that  the  presence  of VAMP  could  define  a  specialized 
class of intracellular GLUT-4 vesicles that are regulated in 
a manner similar to SSVs. 
To date, the nature of the intracellular GLUT-4 com- 
partment is poorly understood. GLUT-4 has been local- 
ized to endosomes and the trans-Gol# reticulum (TGR) and 
to associated tubulo-vesicular elements using immuno-EM 
(Slot et al., 1991a,b). However, it is not clear if the tubulo- 
vesicular elements are subdomains of the TGR/endosomal 
system or a discrete specialized secretory system like SSVs. 
To make this distinction, it will be necessary to undertake 
a high resolution analysis of the protein composition of the 
intracellular  GLUT-4 vesicles.  In  the  present  study, we 
have identified three different synaptobrevin homologues 
in 3T3-L1 adipocytes (VAMP-l, VAMP-2, and cellubre- 
vin). Using endosomal ablation and immuno-EM on intra- 
cellular vesicles isolated from adipocytes, we have compared 
the intracellular distribution of VAMP-2 and cellubrevin 
in adipocytes with GLUT-4. These data provide evidence 
for the intracellular segregation of these different synapto- 
brevins. We have identified at least four separate intra- 
cellular compartments using these markers containing ei- 
ther: a) cellubrevin alone, b) cellubrevin and GLUT-4, c) 
GLUT-4 and VAMP-2, or d) GLUT-4 alone. 
Materials and methods 
Materials 
Restriction enzymes were obtained from New England Biolabs, Inc. (Bev- 
erly,  MA).  Radioactive  nucleotides,  nylon  membranes  (Hybond-N+), 
HRP-coniugated goat anti-rabbit IgG, and enhanced chemi-luminescence 
(ECL) detection kits were from Amersham (Aylesbury, UK). All tissue 
culture reagents were from GIBCO BRL (Gaithersburg, MD), with the 
exception of fetal calf serum, which was from Commonwealth Serum Lab- 
oratory  (Parkville,  Vic, Australia).  Poly(vinylidene ditluoride)  blotting 
membranes  were  from  Millipore  (Bedford,  MA).  Bicinchoninic  acid 
(BCA) protein assay kits were from Pierce (Rockford, IL). Oligonucle- 
otides  were  synthesized on  an  Applied  Biosystems DNA  synthesizer 
(model 394; Foster City, CA). All other chemicals were of high quality 
commercial grades. 
Antibodies 
Antibodies specific for GLUT-4 were raised against a peptide correspond- 
ing to the COOH-terminal 12 amino acids of the rat adipocyte isoform 
(James et al., 1987) for use in immunoblotting, or against the COOH-ter- 
mina117 amino acids for use in immuno-EM. Antibodies specific for GLUT-1 
were raised against a  peptide corresponding to the COOH-terminal  12 
amino acids (Piper et al., 1991). An antibody specific for the human cat- 
ion-dependent mannose 6-phosphate receptor (CD-MPR) cytosolic tail 
was a  gift from Dr. Annette Hille (Universitiit G6ttinggen, G~Sttingen, 
Germany), and is described in Sehulze-Garge et al. (1993).  Affinity puri- 
fied antibodies raised against a  synthetic peptide corresponding to the 
unique NH2-terminal 20 amino acids of rat brain VAMP-2 with an addi- 
tional  NH2-terminal  cysteine  (sequence  SATAATVPPAAPAGQGG- 
PPA(C)) were a gift from Dr. Masami Takahashi (Mitsubishi Kasei Insti- 
tute  of  Medical  Research,  Tokyo).  Affinity-purified  antibody  raised 
against a synthetic peptide corresponding to the NH2-terminal 12 amino 
acids of cellubrevin was provided by Dr. Thomas Siadhof (Southwestern 
Medical School, Dallas, TX), and an antibody raised against a synthetic 
peptide corresponding to the NH2-terminus of VAMP-1 was a gift from 
Dr. Pietro De Camilli (Yale University, New Haven, CT). All synaptobre- 
vin antibodies were specific for their respective isoforms. An antibody 
specific for the a  subunit of the Na-K/ATPase was kindly provided by Dr. 
R. Mercer (Washington University, St. Louis, MO). 
Cell Culture 
3T3-L1  fibroblasts (American Type Culture Collection, Rockville, MD) 
were grown in DME supplemented with 10% newborn calf serum, 2 mM 
L-glutamine, 100 U/I penicillin, and 100 mg/l streptomycin at 37°C in an 
atmosphere of 5% CO2. Cells were passaged at subconfluency. Confluent 
cells were differentiated into adipocytes as described (Frost and Lane, 
1985). Cells were used at day 8 after differentiation. Adipocyte primary 
cultures were isolated from rat epididymal fat by collagenase digestion as 
described previously (Simpson et al., 1983). To establish basal conditions 
before use, 3T3-L1  cells were incubated for 2 h in serum-free DME, and 
primary cultures of rat adipocytes were incubated for 30 min in modified 
KRP (12.5 mM Hepes, 120 mM NaCI, 6 mM KC1, 1.2 mM MgSO4, 1 mM 
CaCI2, 1 mM sodium phosphate, 2 mM sodium pyruvate, 2% BSA, pH 
7.4). When used, insulin was included in the incubation media at 4 v.g/ml 
for 30 min at 37°C. 
Cloning and Sequence Analysis of VAMPs 
in 3T3-L1 Adipocytes 
Two oligonucleotide primers (CGCGGATCCAGCAAACCCAGGCAC- 
AAGTGGA; sense primer and CGCGGATCCTTCCACCAATACTT- 
CCTTIT;  antisense primer) corresponding to the conserved central do- 
main of rat brain VAMP-1 eDNA (Elferink et al., 1989) were synthesized 
and used to obtain a 193-bp DNA fragment by RT-PCR from rat brain 
RNA.  Rat  brain RNA was isolated by the method of Chirgwin et  al. 
(1979). The PCR cycling profile was 94°C for i  min, 55°C for 1 min, and 
72°C for l  min, repeated for 35 cycles. The authenticity of the amplified 
DNA fragment was verified by DNA sequencing. The PCR product was 
isolated from a 1% agarose gel, radiolabeled with random hexamer prim- 
ers (Promega, Madison, WI), and used to probe a randomly primed 3T3- 
L1 adipocyte eDNA library constructed in h ZAP II, kindly provided by 
Dr. F. Fiedorek (University of North Carolina, Chapel Hill, NC). A total 
of 250,000  plaques were screened. From 14 positives, isolated after se- 
quential purifications, two distinct cDNAs, VAMP-1 and cellubrevin, were 
identified. The 3T3-L1  adipocyte eDNA library was also screened with a 
labeled rat brain VAMP-2 eDNA, kindly provided by Dr. Masami Taka- 
hashi. A total of 250,000 plaques were screened, and from 36 positives iso- 
lated, four were sequenced and  found to be homologous to  rat  brain 
VAMP-2. Positive clones were sub-cloned into pBluescript II SK- (Strata- 
gene, La Jolla, CA) and sequenced manually using Sequenase (version 
2.0; U.S. Biochemical Corp., Cleveland, OH) or by automated DNA se- 
quencing (model 373A; Applied Biosystems Inc.). All cDNAs were se- 
quenced in both strands. 
Preparation of  Membranes 
Preparation of  Membmnes for lmmunobiotting. All steps were performed at 
4°C or on ice. 3T3-L1  cells were grown in 100-mm culture dishes, scraped 
into 5 ml of HES Buffer (20 mM Hepes, 250 mM sucrose, 1 mM EDTA, 
pH 7.4) containing 10 p~g/ml leupeptin, 10 p.g/ml aprotinin, and 250  p~M 
PMSF, and homogenized by 10 passes through a 22-gauge needle. The ho- 
mogenate was centrifuged at 60,000 rpm (model TLA100.3; Beckman In- 
struments, Fullerton, CA) for 60 min. The membrane pellets were resus- 
pended and  solubilized in PBS  (137  mM NaCI, 2.7  mM KCI,  1.5  mM 
KH2PO4, 8.0 mM Na2HPO4, pH 7.4)/0.1%  SDS for 1 h. Insoluble material 
was removed by centrifugation in a microfuge for 10 min. The superna- 
tants were assayed for protein using the BCA assay and used to prepare 
Laemmli gel samples. 
Sub-cellular Fractionation of 3T3-L1 Adipocytes. Cells  were  homoge- 
nized in HES buffer containing protease inhibitors by 10 passes through a 
homogenizer (Balch et al., 1984) using a 0.0011" clearance ball bearing. 
Subcellular fractionation was performed as described previously (Simpson 
et al., 1983; Piper et al., 1991). This fractionation procedure, which sepa- 
rates membrane fractions on the basis of differential centrifugation, gen- 
erates four membrane fractions. The M/N fraction is enriched in mito- 
chondria  and  nuclei  and  contains little  GLUT-4  or  other  endosomal 
markers (Simpson et al., 1983; James and Pilch, 1988; Piper et al., 1991). 
The plasma membrane (PM) fraction is highly enriched in plasma mem- 
brane markers such as the a subunit of the Na-K/ATPase (see Fig. 2). The 
HDM is enriched in ER markers (Simpson et al.,  1983) and fluid phase 
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Pilch, 1988). The LDM contains Golgi markers, recycling endosomes, and 
the majority of the insulin-regulatable GLUT-4 compartment (Simpson et 
al., 1983; James and Pilch, 1988; Piper et al., 1991). 
Preparation of Vesicles  for lmrauno-EM.  When vesicles were prepared 
for immuno-EM, cells were resuspended in 2x vol. HES buffer containing 
protease inhibitors and homogenized using a 22-gauge needle. The homog- 
enate was centrifuged at 13,000 rpm for 20 min (model SS-34;  Sorvall In- 
struments, Wilmington, DE) to remove cell debris, mitochondria, nuclei, 
and plasma membranes. The supernatant was layered onto a  1.5 M  su- 
crose cushion (1 ml) containing Hepes (pH 7.4, 20 mM) and EDTA (1 mM) 
and centrifuged at 30,000 rpm for 60 min using a Beckman rotor (model 
SW-41). The intracellular membrane vesicles above the  1.5  M  sucrose 
cushion were harvested and immediately fixed in a final concentration of 
2% paraformaldehyde/PBS or incubated with 1 M KCI for 10 min before 
fixation. Fixed membranes were stored at 4°C. 
Endosome Ablation 
The transferrin/HRP-conjugate (Tf/HRP) was prepared using the carbo- 
diimide method of Kishida et al. (1975). HRP (10 mg) was dissolved in 
0.1 M NaCI and 10 mM sodium phosphate, pH 7.2 (1 ml), at 4°C and dia- 
lyzed overnight against the same buffer. Disodium succinate (200 mg) and 
succinic anhydride (70 mg) were added to the protein solution, and this 
was stirred for 30 min at 0°C and for 30 min at room temperature, and 
then passed over an 8-ml G-50 Sephadex column. The solution was con- 
centrated to 0.5 ml using a centriprep concentrator (Amicon, Beverly, MA). 
N-hydroxysuccinimide (25  mg)  and  N-ethyl-n-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (40 mg) were added and the solution stirred 
for 3 h at 0°C. This was again passed over an 8-ml G-50 Sephadex column 
in 0.1 M  NaC1/1  mM sodium phosphate, pH 7.2, and the eluate was col- 
lected.  This activated HRP was immediately added  to  1  ml phosphate 
buffer containing transferrin (10 mg/ml) and 125I-transferrin (107 cpm) and 
stirred for 2 d at 2°C. The conjugation reaction was quenched by addition 
of excess glycine and a  sample of the reaction run on a  10% polyacryl- 
amide gel to  check,  by  autoradiography, for  an increase  in  molecular 
weight of a proportion of the iodinated transferrin. Samples from three re- 
actions were  pooled  and chromatographed on a  75  ×  2-cm Sephacryl 
S-300 column in order to separate unconjugated transferrin from the Tf/ 
HRP conjugate. Conjugate was aliquotted and stored at -80°C until use. 
The conjugate was iron loaded as described by West et al. (1994). 
After 2 h in serum-free DME, 3T3-L1 adipocytes were incubated with 
20 }xg/ml Tf/HRP for the times indicated. Cells were chilled by washing in 
ice-cold isotonic citrate buffer and kept on ice to prevent further vesicle 
trafficking during the DAB cytochemistry reactions. Cell surface-attached 
Tf/HRP was removed by acid washing for 10 min in ice-cold isotonic cit- 
rate buffer (150 mM NaCI and 20 mM sodium citrate, pH 5.0) with three 
changes of buffer and then the monolayer was washed once in ice-cold 
PBS, pH 7.4. Cells were incubated with DAB (100 Ixg/ml) in the absence 
or presence of H202 (0.02%, vol/vol) for 60 min at 4°C in the dark. Cells 
were washed once with PBS containing 5 mg/ml BSA and three times with 
ice-cold HES buffer before subcellular fractionation. GLUT-4-containing 
vesicles were immunoabsorbed from the LDM fraction as previously de- 
scribed (Martin et al., 1994). 
SDS-PAGE and Western Blotting 
SDS-PAGE was performed by the method of Laemmli (1970) using 10 
or 15% acrylamide resolving gels. Proteins resolved by SDS-PAGE were 
electrophoretically transferred to poly(vinylidene difluoride) by the method 
of Towbin et al. (1979). Membranes were incubated with rabbit polyclonal 
antibodies specific for either VAMP-1 (1:250), VAMP-2 (10 p,g/ml), cellu- 
brevin (1:1,000), GLUT-1 (5 p~g/ml), GLUT-4 (1:500), or the at subunit of 
the Na-K/ATPase (1:500).  Immunoreactive proteins were detected using 
HRP-conjugated goat anti-rabbit IgG (1:10,000)  and ECL. 
Electron Microscopy 
Paraformaldehyde-fixed intracellular membrane vesicles were randomly 
adsorbed to form var-coated copper grids. Dry grids were layered on 10-1xl 
drops of vesicle suspensions and floated on them for 10 mln. The non- 
bound vesicles were washed away during the sequential incubations de- 
scribed below.  All subsequent incubations of grids were performed on 
~500-p,l drops at room temperature unless stated otherwise. Grids were 
incubated sequentially on 2% gelatin for 10 min, 0.02 M glycine/PBS (4 x 
1 rain), and 0.1% BSA/PBS for 1 min. Grids were then incubated with 10-1xl 
drops of primary antibodies diluted in 1% BSA/PBS as follows: GLUT-4 
serum (1:400), VAMP-1 IgG (1:100), VAMP-2 IgG (10 ixg/ml),  cellubre- 
vin IgG (1:500),  and CD-MPR serum (1:100).  After a 30-min incubation, 
grids were washed four times with 0.1%  BSA/PBS and then incubated 
with 20 ~1 gold-conjugated protein A in 1% BSA/PBS for >30 min. Grids 
were then washed with 0.1% BSA/PBS for 5 rain and then four times with 
PBS for 5 min each. The reaction was stabilized by a 5-min incubation in 
1% glutaraldehyde/PBS. When double labeling was performed, grids were 
washed twice for 5 min with PBS and five times for 2 min each with 0.02 M 
glycine/PBS, after which the above procedure was repeated using a differ- 
ent primary antibody and different-sized protein A-gold conjugate. All 
grids were then washed twice for 5 min with PBS, five times for 2 min with 
ultrapure water, and stained with uranyl acetate/methyl cellulose (1:9; 4% 
uranylacetate in 0.15 M oxalic acid, pH 7-8: 2% methylcellulose) for 5 min. 
Grids were dried and viewed using a  transmission electron microscope 
(model 1010; JEOL U.S.A., Inc., Peabody, MA). 
Results 
Cloning and Sequencing of  3T3-L1 
Adipocyte Synaptobrevins 
To  identify synaptobrevin isoforms expressed in  adipo- 
cytes, a  3T3-L1 adipocyte eDNA expression library was 
screened with rat brain VAMP-1 or VAMP-2 eDNA probes. 
Full length clones encoding VAMP-l, VAMP-2, and cellu- 
brevin were isolated and characterized. Both 3T3-L1 adi- 
pocyte VAMP-2, and cellubrevin were 100% identical to 
their respective rat brain  homologues at the  amino acid 
level. VAMP-l, the least abundant VAMP homologue de- 
tected in adipocytes, was 96% identical to the rat brain se- 
quence  (Elferink  et  al.,  1989)  at  the  amino  acid  level. 
There were substitutions  (rat brain ---> 3T3-L1) at amino 
acid residues 28 (T ---> M), 48 (I -->M), 78 (V --> Q), and 116 
(I --> F). One of these changes, V78 in rat to Q78 in mouse, 
occurred within  the putative tetanus  toxin cleavage site 
and may render murine VAMP-1  tetanus toxin sensitive. 
In this respect, murine VAMP-1  more closely resembles 
the human (Archer et al., 1990) and drosophila (Stidhof et 
al.,  1989) brain VAMP-1  homologues than the rat brain 
homologue. Similarly, the amino acid substitution I48 to 
M48 changes the distal recognition site for botulinum D 
toxin to that found in VAMP-2  (Yamasaki  et al.,  1994) 
suggesting that murine VAMP-1 also has increased sensi- 
tivity to this toxin. 
Fig. 1 shows a representative immunoblot of the tissue 
distribution of cellubrevin, VAMP-l, and VAMP-2. Cellu- 
brevin is ubiquitously expressed, which is consistent with 
previous studies (McMahon et al., 1993). VAMP-2 is ex- 
pressed at high levels in brain, but it was also detected in 
all tissues that exhibit insulin-regulated glucose transport. 
All three synaptobrevin isoforms were detected in 3T3-L1 
fibroblasts. After differentiation of these cells into adipo- 
cytes, the expression of VAMP-2 increased 2.4-fold, and 
on average there was also a slight (1.2-fold) increase in the 
expression  of  cellubrevin  (Fig.  1).  An  immunoreactive 
species corresponding to VAMP-1 could not be detected 
in 3T3-L1 adipocytes. 
SubceUular Distribution of Synaptobrevins 
in Adipocytes 
To identify the cellular location of synaptobrevins, adipo- 
cytes were incubated in the presence or absence of insulin 
and then subjected to subcellular fractionation followed 
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rat tissues and 3T3-L1 cells. Total cell membranes were prepared 
from rat tissues and from 3T3-L1 fibroblasts and adipocytes. The 
distribution  of synaptobrevins were then determined by immuno- 
blotting.  Equal amounts (50 Ixg) of cell membranes were sepa- 
rated by SDS-PAGE and analyzed by immunoblotting using anti- 
sera specific for VAMP-l, VAMP-2, or cellubrevin (Ceb). 
by immunoblotting (Fig. 2). This fractionation procedure 
has been used extensively to study the subcellular distribu- 
tion  of glucose transporters  and  other markers in  adipo- 
cytes (Cushman and Wardzala, 1980; Simpson et al., 1983; 
James et al., 1987; James and Pilch, 1988; Piper et al., 1991; 
Cain et al., 1992; Hanpeter and James, 1995). Relevant to 
the present studies, endosomal markers such as internal- 
ized transferrin (Livingstone et al., 1996), internalized in- 
sulin (James and Pilch, 1988), and the transferrin receptor 
(Hanpeter and James, 1995)  are enriched predominantly 
in the  LDM fraction and to a  lesser extent in the  HDM 
fraction. In agreement with previous studies, the ct subunit 
of the Na-K/ATPase, a  cell surface marker, is highly en- 
riched in the PM fraction (Fig. 2) and its distribution is un- 
affected by insulin. In the absence of insulin, GLUT-4 was 
found both in the LDM (~60%) and the HDM (N30%). 
In  response  to  insulin,  there  was  a  four-  to  fivefold in- 
crease in the  level of GLUT-4 in  the  PM, a  twofold de- 
crease  in  the  LDM,  and  a  slight  decrease  in  the  HDM. 
These data support previous studies showing that insulin 
stimulates  the  movement of GLUT-4 from  intracellular 
membranes (LDM) to the cell surface (PM). 
We were unable to detect a significant difference in the 
subcellular distribution of VAMP-2 and cellubrevin using 
this procedure (Fig. 2).  Both synaptobrevin isoforms un- 
derwent  insulin-dependent  translocation  from the  LDM 
fraction to the cell surface. However, the magnitude of the 
insulin-dependent  increase  at  the  cell  surface  was  much 
less for VAMP-2 and cellubrevin (two- to threefold, n  = 4) 
compared to GLUT-4 (four- to fivefold, n  =  4). This dif- 
ference mainly reflected the very low levels of GLUT-4 in 
the plasma membrane of non-stimulated cells, whereas this 
was not the case for each of the synaptobrevins (Fig. 2). 
Figure 2.  Subcellular distribution  of VAMP-2 and cellubrevin in 
basal and insulin-stimulated 3T3-L1  adipocytes. Basal (-) or 
insulin-stimulated  (+) 3T3-L1 adipocytes  were subjected  to dif- 
ferential centrifugation.  Samples containing  either plasma mem- 
branes (PM), low density microsomes (LDM), high density micro- 
somes (HDM), or mitochondria/nuclei  (M/N), each containing 
50 Ixg protein, were separated by SDS-PAGE and analyzed  by 
immunoblotting using antisera specific for Na-K/ATPase, GLUT-4, 
VAMP-2, or cellubrevin (Ceb). 
Similar  results  comparing  the  distribution  of  GLUT-4, 
VAMP-2, and cellubrevin were also obtained in primary 
cultured rat adipocytes (data not shown). 
Co-localization of VAMP-2, CeUubrevin, and GLUT-4 
with the Transferrin Receptor 
A  technique has been previously developed to investigate 
the recycling of proteins through endosomal compartments 
utilizing HRP-catalyzed complexing of DAB  with neigh- 
boring  lumenal  and  integral  membrane  proteins  in  the 
presence  of hydrogen  peroxide  (Stoorvogel et  al.,  1988, 
1989,  1991; West et al., 1994). By allowing cells to take up 
Tf/HRP before DAB/peroxide treatment, the compartments 
containing the TfR, specifically early endosomal compart- 
ments, can be selectively segregated from other compart- 
ments. In view of the high number of transferrin receptors 
expressed  in  3T3-L1  adipocytes  (Tanner  and  Lienhard, 
1987,  1989), it is possible to use this technique to study the 
composition  of the  endosomal  system in  these  cells.  In 
combination  with  the  subcellular  fractionation  program 
described here (Fig. 2), it is possible to determine the rela- 
tionship between the endosomal system and intracellular 
compartments containing  GLUT-4 and  other markers in 
adipocytes. The  LDM fraction was used  for all of these 
studies because it is highly enriched in the insulin-regulat- 
able  GLUT-4 compartment (Fig.  2).  We  have used  this 
technique to show that GLUT-4, GLUT-l, and the cation- 
independent  MPR/insulin-like  growth  factor  II receptor 
partially co-localize with the TfR in the endosomal system 
of 3T3-L1  adipocytes (Livingstone  et al.,  1996),  which  is 
consistent with previous studies using vesicle immunoad- 
sorption  (Piper  et  al.,  1991;  Hanpeter  and  James,  1995). 
TGN38, a membrane protein that is predominantly found 
in  the  TGR  at  steady  state,  was  not  ablated  following 
treatment with Tf/HRP (Livingstone et al., 1996), indicat- 
ing that this technique is reasonably specific for recycling 
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through a change in vesicle density (density shift) or due to 
chemical cross-linking of proteins that are located within 
the lumen of the same compartment as the Tf/HRP conju- 
gate. We have observed both types of modification in 3T3- 
L1  adipocytes  treated  with  Tfft-IRP (Livingstone  et  al., 
1996).  Irrespective  of  the  mechanism  of  ablation,  this 
method provides a  powerful approach for identifying the 
composition of the recycling/endosomal system. 
3T3-L1  adipocytes  were  incubated  with  the  Tf/HRP 
conjugate for either 1 or 3 h  at 37°C.  DAB cytochemistry 
was then performed in the presence or absence of perox- 
ide and the amount of GLUT-4, VAMP-2, and cellubrevin 
in the LDM was determined by immunoblotting (Fig. 3). 
Quantitative ablation of the TfR (Livingstone et al., 1996) 
and cellubrevin (Table I) was achieved following either a 1 
or  3  h  incubation  with  the  conjugate.  In  contrast,  only 
about 40% of the GLUT-4 and 10% of VAMP-2 found in 
the LDM fraction was removed under similar conditions. 
Longer incubation  of the cells (3 h  at 37°C) with the Tf/ 
HRP conjugate confirmed that this result was not due to a 
difference  in  time  required  for  the  TfR  to  enter  the 
VAMP-2-containing intracellular site. As endocytotic and 
exocytotic recycling of proteins is temperature-dependent, 
incubating the cells for 3 h  at 4°C confirmed that the ob- 
served results were due to membrane recycling, as at this 
temperature  neither  VAMP-2  nor  cellubrevin  were  re- 
moved. 
To confirm the segregation of VAMP-2 and cellubrevin 
in the intracellular LDM fraction isolated from 3T3-L1 ad- 
ipocytes,  further  experiments  using  vesicle  immunoad- 
sorption were performed. Adipocytes were incubated with 
Tf/HRP and some were treated with peroxide. Intracellu- 
lar membranes (LDM) were isolated and incubated with 
Figure 3.  Effect of ablation of the TfR endocytotic pathway on 
VAMP-2 and cellubrevin  in the LDM fraction of 3T3-L1 adipo- 
cytes. Nonstimulated 3T3-L1 adipocytes were incubated with Tf/ 
HRP for either 1 or 3 h at 37°C, or for 3 h at 4°C. DAB cytochem- 
istry was then performed either in the presence (+) or absence 
(-) of hydrogen peroxide. Cells were homogenized and intracel- 
lular membranes harvested following differential  centrifugation. 
Intracellular membrane fractions,  corresponding to 10% of that 
isolated from a single 10-cm plate of cells, were subjected to SDS- 
PAGE  followed  by immunoblotting with  antisera  specific  for 
VAMP-2, cellubrevin (Ceb), or GLUT-4. 
Table L Effects of Tf/HRP Ablation on lntracellular GLUT-4 
and Synaptobrevin  Levels 
Incubation conditions 
37°C, 1 h  37°C, 3 h  4°C, I h 
n*  --  +  -  +  -  + 
GLUT-4  6  100  105 4-8  102 4-6  63 ±-6  103±7  61-2 
VAMP-2  3  100  103±-  14  101  ±3  90 4- 11  104±8  88±9 
Ceb  3  100  98+_6  107+-  11  104-4  101  ±  14  17_6 
3T3-LI adipocytes  were treated with Tf/HRP for either I h or 3 h at 37°C or for 3 h at 
4°C, after which the DAB cytochemistry reaction was performed in the presence (+) 
or the absence (-) of hydrogen peroxide. After subcellular fractionation, the LDMs 
were immunoblotted for the proteins shown. The data is expressed as a percentage +- 
SEM  of the  amount of protein present in control samples (control samples were 
treated with Tf/HRP for 3 h  at 4°C, after which the DAB cytochemistry was per- 
formed in the absence of hydrogen peroxide). The GLUT-4 signal was detected using 
an iodinated anti-rabbit IgG and the radioactive bands quantified by gamma counting. 
The VAMP-2 and cellubrevin signals were detected by ECL and quantified using den- 
sitometry. 
* Number of blots quantified (where n  =  3, this is from three separate ablation exper- 
iments). 
an antibody specific for the cytoplasmic carboxyl terminus 
of GLUT-4 to  immunoadsorb  GLUT-4-containing  vesi- 
cles  (Fig.  4).  GLUT-4--containing vesicles isolated  from 
nonablated cells contained both VAMP-2 and ceUubrevin, 
indicating that these three proteins colocalize. Vesicles iso- 
lated from ablated cells, however, contained only VAMP-2 
(Fig. 4). These data confirm the above findings (Fig. 3) and 
suggest that there are at least two distinct populations of 
GLUT-4-containing vesicles in adipocytes: one that is en- 
riched  in  ceUubrevin  and  another  that  is  enriched  in 
VAMP-2. Equivalent control vesicles isolated using non- 
specific IgG contained neither cellubrevin nor VAMP-2. 
To ensure that the majority of the GLUT-4-containing 
vesicles were being adsorbed from the  LDMs, the mem- 
branes remaining in the supernatant after imrnunoadsorption 
were also blotted for VAMP-2, cellubrevin, and GLUT-4. 
The amount of GLUT-4 remaining after immunoadsorp- 
tion was found to be less than 5% of the level present in 
the LDMs absorbed with nonspecific IgG, confirming that 
most of the GLUT-4-containing vesicles had been immu- 
noadsorbed  (results  not  shown).  In control  cells,  immu- 
noadsorption  of GLUT-4-containing vesicles resulted  in 
the  removal of most VAMP-2  and  cellubrevin  (Fig.  4), 
compared to the levels remaining after control immunoad- 
sorption with nonspecific IgG. In treated  cells,  GLUT-4 
removal also resulted  in  VAMP-2  removal compared to 
control  immunoadsorption.  However,  cellubrevin  could 
not be detected regardless of whether specific anti-GLUT-4 
IgG or nonspecific IgG was used. As cellubrevin is also not 
present  in  the  equivalent  vesicle  preparation,  this  con- 
firmed its  removal from the  LDM.  These  data  indicate 
that  VAMP-2  and  a  substantial  proportion  of  GLUT-4 
must be located in an intracellular compartment(s) distinct 
from the endosomal system that contains the TfR and cel- 
lubrevin. 
To determine if the nonablated component of VAMP-2 
and  GLUT-4 could arise from the biosynthetic pathway, 
similar studies to those  described above were performed 
in 3T3-L1 adipocytes following incubation with cyclohex- 
imide (20 ixg/ml or 50  Ixg/ml) for either 45 rain or 2  h  at 
37°C,  conditions  that have previously been shown to in- 
hibit protein synthesis (Piper et al., 1992).  However, there 
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synthesised GLUT-4 or VAMP-2, as this compartment per- 
sisted in cells following incubation with cycloheximide. To 
further  investigate  the  nature  of this  compartment,  im- 
muno-EM was performed on adipocyte intracellular vesi- 
cles. This technique provides several advantages not avail- 
able using other methods, such as subcellular fractionation 
or immunocytochemistry in tissue or cell sections. First, it 
is possible to analyze the protein composition of a uniform 
population of vesicles. Thus, in order to examine the en- 
tire  intraceUular  GLUT-4 compartment in  these  experi- 
ments, we isolated a membrane fraction that represented a 
combined HDM/LDM fraction. Whereas the majority of 
membranes in this fraction comprised small vesicles of an 
average diameter 80 nm, larger structures were occasion- 
ally observed and approximately 5 % of these were labeled 
to varying degrees for GLUT-4, VAMP-2, and cellubrevin 
(see Fig. 5). These structures are presumably derived from 
early endosomal vacuoles or interconnected structures de- 
rived from the TGR. In view of their size, these are likely 
to be the major component of the HDM fraction. In addi- 
tion, these strucutures are not observed in the LDM frac- 
tion (data not shown). Second, it is possible to detect vari- 
ations in protein content across a  population of vesicles. 
Third,  the labeling obtained using this technique is typi- 
cally quite high because of the mild fixation conditions and 
because labeling of whole vesicles can be achieved. For ex- 
Figure 4.  Effect of TfR pathway ablation on the immunoadsorp- 
tion  of GLUT-4-containing  vesicles from  3T3-L1 adipocytes. 
3T3-L1 adipocytes were loaded with Tf/HRP for 1 h at 37°C. Af- 
ter DAB cytochemistry in the presence (+) or absence (-) of hy- 
drogen  peroxide,  cells were  subjected  to  subcellular  fraction- 
ation. GLUT-4--containing vesicles were then immunoadsorbed 
as described previously (Martin et al., 1994). Formaldehyde-fixed 
Staphylococcus aureus cells were incubated  with GLUT-4 anti- 
bodies (G4) or nonspecific IgG (IgG). This complex was then in- 
cubated  with an  intracellular  LDM fraction  isolated  from  the 
3T3-L1 adipocytes. The pellets containing the immunoadsorbed 
complex and the supernatant,  containing the nonadsorbed mem- 
branes, were subjected to SDS-PAGE followed by immunoblot- 
ting using antisera specific for VAMP-2 or cellubrevin (Ceb). 
was no significant change in the ablation efficiency follow- 
ing incubation with cycloheximide (data not shown), indi- 
cating  that  the  nonablated  component of GLUT-4 and 
VAMP-2 does not correspond to newly synthesized protein. 
lmmuno-electron Microscopy on Adipocyte Vesicles 
DAB/peroxide  complexation  of  the  3T3-L1  adipocyte- 
recycling endosomal pathway and  immunoadsorption of 
GLUT-4 vesicles from intracellular membranes indicated 
that VAMP-2 colocalizes with GLUT-4 outside of the gen- 
Figure 5.  Immunoelectron microscopy labeling of larger, compli- 
cated structures in intracellular membranes from rat adipocytes. 
An intracellular membrane fraction was prepared from rat adipo- 
cytes and fixed in 2% paraformaldehyde. After adsorption to EM 
grids, these  membranes  were immunolabeled  for GLUT-4 and 
VAMP-2 and specific labeling detected using 5- and 10-nm gold, 
respectively. Occasional labeling of large, complicated membrane 
structures was observed, as well as the labeling of small (50-140 
rim) vesicles. Shown is one of the heavily labeled large structures 
together with both labeled and unlabeled vesicles. Bar, 100 nm. 
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contained >30 gold particles per vesicle. Finally, it is pos- 
sible to colocalize different antigens in the same field of 
vesicles using secondary antibodies conjugated with differ- 
ent-sized gold particles. 
Due to the relatively low expression of VAMP-2 in 3T3- 
L1 adipocytes, it was not possible to detect immunogold 
labeling  on  vesicles  isolated  from these  cells  (data  not 
shown). However, VAMP-2 is expressed at higher levels 
in rat adipocytes and intracellular vesicles isolated from 
these  cells  yielded consistent  specific VAMP-2  labeling 
(Table  II).  Therefore, an  extensive  analysis  at  the  im- 
muno-EM level was performed on vesicles isolated from 
these cells. No specific VAMP-1 labeling was detected in 
adipocyte vesicles, probably because of its very low ex- 
pression in these cells (data not shown). We observed sig- 
nificant variation in labeling for different antigens (see Ta- 
ble  II).  This may be  due  to  epitope  masking,  different 
levels of protein expression, or differential sensitivity to 
the fixative. However, this caveat only becomes problem- 
atic, at least in the present studies, if the low labeling effi- 
ciency results in an underestimation of the total number of 
vesicles containing a particular antigen. However, as de- 
scribed below this does not appear to be the case. 
The  overall  labeling  for  GLUT-4  was  much  higher, 
ranging from 3->30 gold particles per vesicle, than cellu- 
brevin (2-6 particles per vesicle) or VAMP-2 (1-3 particles 
per  vesicle).  We  attempted  to  determine  if  the  low 
VAMP-2 labeling was related to epitope masking or to the 
particular antibody used. Vesicles were incubated with ei- 
ther  1  M  KCI,  glycine  buffer,  pH  2.4,  or  bicarbonate 
buffer, pH 11.9,  before fixation. However, none of these 
treatments had a significant effect on VAMP-2 labeling. In 
addition, we obtained essentially identical results with two 
separate VAMP-2 antibodies. Thus, we found no evidence 
for selective protection of the VAMP-2 epitope. In addi- 
tion  to  variations  in  antigen  labeling  per  vesicle, there 
were also differences in the percentage of total vesicles la- 
beled for each marker (Table II). However, there was no 
correlation between these two parameters. For instance, 
the  percent  of total  vesicles containing  cellubrevin and 
GLUT-4 was similar (31 and 36%, respectively), but the 
Table II. Analysis of the Protein Composition of Adipocyte 
Vesicles Determined Using Immuno-EM 
Analysis of labeling  Percentage overlap with ¢ 
Vesicles  Percentage 
containing*  total  Range  GLUT-4  VAMP-2  Ceb  MPR 
GLUT-4  36 ±  7  3-25  100  26 ±  6  46 +  1  48 ±  7 
VAMP-2  12±  1  1-3  87-5  100  63±3  36--. 1 
Ceb  31  -  2  2-6  66 ±  4  24 -+ 5  100  54 --- 4 
MPR  23 --- 7  1-11  76 --- 2  45 ±  5  63 ±  6  100 
Fixed vesicles from adipocytes were single or double labeled as described in Materi- 
als and Methods. The percentage of the total vesicles present in the membrane fraction 
used that were labeled with each antibody (Percentage total), and the range of gold la- 
beling per vesicle (Range) was determined by single labeling. To determine colocal- 
ization, double labeling was performed. For each pool of the total vesicles labeled for 
a primary marker, (*) the degree of overlap with a second marker protein (*) was de- 
termined. The degree of overlap is expressed as a percentage only of the pool contain- 
ing the first labelled protein (i.e.  36% of the total vesicles contain GLUT-4, and 26% 
of that  36%  also  contain VAMP-2).  Between  200-300 individual vesicles  were 
counted to determine percent overlap between each marker. Shown are the means ~- 
SEM of three separate vesicle preparations. 
overall labeling per vesicle was much higher for GLUT-4 
(Table II). These data suggest that the labeling obtained 
using these different antibodies provides a reasonably ac- 
curate representation of the distribution of the majority of 
these different proteins. The diameter of the vesicles la- 
beled varied over the range 50-140 nm, with an average 
vesicle diameter of 80 nm. There was no correlation be- 
tween vesicle size and specific protein content. 
Once the single-labeling profiles had been determined 
for each of the antibodies, double labeling was used to de- 
termine the extent of overlap between different antigens. 
Characteristic double labeling of vesicles is shown in Fig. 6 
and quantitation of the overlap between different markers 
is shown in Table II. In interpreting these data, it is impor- 
tant to recognize the variation in the pool size for the dif- 
ferent antigens. For example, the total number of vesicles 
containing GLUT-4 (36%) is much larger than the total 
number of VAMP-2 vesicles (12%). Thus, despite the very 
high degree of overlap between these two markers, only 
26% of vesicles that contain GLUT-4 also contain VAMP-2. 
Almost  half of the  GLUT-4 (+ve)  vesicles contained 
cellubrevin and nearly a quarter contained VAMP-2. Con- 
versely, almost  all  of the  VAMP-2  (+ve)  vesicles con- 
tained GLUT-4, whereas in the case of cellubrevin (+ve) 
vesicles, there was  a  significant population of these that 
were GLUT-4 (-ve). In conjunction with the Tf/HRP ab- 
lation data, where about half of the GLUT-4 was ablated 
under conditions that ablate almost all of the ceUubrevin, 
these data suggest that those GLUT-4 (+ve)/cellubrevin 
(+ve) vesicles observed by immuno-EM colocalizing with 
cellubrevin must partly derive from the recycling endoso- 
mal pool. However, only a relatively small proportion of 
VAMP-2 was  ablated following incubation with Tf/HRP 
(Table I), yet 63% of the VAMP-2 (+ve) vesicles contain 
cellubrevin (Table II). Because the VAMP-2 pool size is 
much smaller than the cellubrevin pool (12 versus 31%, 
Table II), we would have predicted that the VAMP-2 pool 
would only contain 18% of the total amount of cellubre- 
vin. This value is very close to the measured amount of 
nonablated cellubrevin following incubation with Tf/HRP 
(Table I). Thus, we assume that the majority of VAMP-2 
(90%, Table I) sorts into a separate compartment from the 
recycling  endosomes  together  with  a  large  proportion 
(>60%, Table I)  of the  recycling GLUT-4. Other recy- 
cling proteins, such as cellubrevin and MPR, also sort into 
this compartment but with a much lower fidelity. So, the 
majority of these proteins remain in the recycling com- 
partment together with the TfR and thus are subject to ef- 
ficient ablation (Table I). 
Although it was not possible to visualize VAMP-2 label- 
ing of vesicles isolated from 3T3-L1 adipocytes, it was pos- 
sible to detect GLUT-4 and cellubrevin labeling of 3T3-L1 
adipocyte vesicles. In these cells, the segregation of cellu- 
brevin and GLUT-4 was  consistent with the  results  ob- 
tained in rat adipocytes. A  significant proportion of the 
GLUT-4 (50%) was localized to vesicles that did not con- 
tain  cellubrevin, and  60%  of the  cellubrevin containing 
vesicles were GLUT-4 negative (data not shown). 
The TfR and cellubrevin are likely to be predominantly 
located in early endosomes, and so one possible explana- 
tion for the results obtained in this study is that a  large 
proportion of GLUT-4 may reside in a late endosomal corn- 
Martin et al. Segregation of GLUT-4 and VAMP-2  in Adipocytes  631 Figure 6.  Immunoelectron microscopy of intracellular  vesicles from rat adipocytes. An intracellular  membrane fraction was prepared 
from rat adipocytes,  fixed in 2% paraformaldehyde, and adsorbed to EM grids. The grids were then labeled with specific antibodies, 
which were detected using protein A conjugated to different sizes of gold. (A-C) Colocalization  of GLUT-4 (5-nm gold) and VAMP-2 
(10-nm gold). (D-F) Colocalization of GLUT-4 (5-nm gold) and cellubrevin (10-nm gold). (G-H) Colocalization of GLUT-4 (5-nm gold) 
and the CD-MPR (10-nm gold). Bar, 100 nm. 
partment that is not  accessible using the  Tf/HRP conju- 
gate. To test this possibility, we conducted localization stud- 
ies  using  antibodies  specific  for  the  CD-MPR,  as  this 
receptor predominantly recycles between the  Golgi, late 
endosomes, and cell surface (Duncan and Kornfeld, 1988). 
Antibodies specific for the CD-MPR labeled a subpopula- 
tion (~23%) of vesicles isolated from rat adipocytes at an 
efficiency of 1-11 gold particles per vesicle. Double-labeling 
experiments revealed that the CD-MPR was partially colo- 
calized with VAMP-2, GLUT-4, and cellubrevin (Table II). 
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GLUT-4 in that 76% of the CD-MPR (+ve) vesicles also 
contained GLUT-4. However, this only represented 48% 
of the  total  GLUT-4  (+ve)  vesicles.  Only  36%  of the 
VAMP-2  vesicles contained  the  CD-MPR;  therefore,  a 
large proportion of the MPR is excluded from the GLUT- 
4(+ve)NAMP-2(+ve) vesicle pool. 
Discussion 
In this study we have shown that insulin-sensitive cell types 
express  three  different  synaptobrevin  homologues  that 
have previously been shown to be involved in recycling to 
the cell surface (Schiavo et al., 1992; Stidhof et al., 1993; 
Galli et al., 1994). The two most abundant isoforms, cellu- 
brevin and VAMP-2, are located in intracellular vesicles to- 
gether  with  the  insulin  regulatable  glucose  transporter 
GLUT-4 and undergo insulin-dependent movement to the 
cell surface in adipocytes. Using immuno-EM on intracellular 
vesicles isolated from adipocytes, we present evidence that 
GLUT-4 is segregated into distinct intracellular subcompart- 
ments as determined by the overlapping yet distinct colo- 
calization with  cellubrevin and VAMP-2.  These findings 
were  verified using  independent  biochemical techniques 
indicating that the segregation of these markers among dif- 
ferent vesicles was not due to epitope masking or differen- 
tial labeling efficiencies of the various antibodies. Incubation 
of 3T3-L1 adipocytes with Tf/HRP at 37 ~C for 1-3 h fol- 
lowed by incubation with DAB/HeO2 resulted in ablation 
of >90% of the TfR (Livingstone et al., 1996), >80% of cel- 
lubrevin, and ~40% of GLUT-4 found in the intracellular 
LDM fraction (Table I). Most of the VAMP-2 (~90%) and 
,-~60% of GLUT-4 was recovered in the nonablated fraction. 
These results suggest that v-SNAREs may be differentially 
localized within the recycling system in adipocytes and that 
a large proportion of intraceUular GLUT-4, together with 
VAMP-2, is segregated in a postendocytic compartment. 
Previous studies have identified synaptobrevins in insulin- 
sensitive cells (Cain et al., 1992). However, it was not pos- 
sible  to distinguish  between the  different synaptobrevin 
homologues because antibodies against the conserved cen- 
tral domain of VAMP-2 were used to immunoblot adipo- 
cyte membranes. We have identified different synaptobre- 
vins in adipocytes by screening a 3T3-L1 adipocyte cDNA 
expression library with cDNA probes encoding rat brain 
synaptobrevin isoforms. We opted to use a cDNA library 
derived from 3T3-L1 adipocytes as opposed to either mus- 
cle or adipose tissue to avoid potential contamination with 
cDNAs  of nonparenchymal  origin,  particularly  nervous 
tissue.  Full  length  cDNA  clones  encoding  cellubrevin, 
VAMP-l,  and VAMP-2 were identified. Isoform-specific 
antibodies  against  the  extreme amino  terminus  of each 
synaptobrevin isoform were used to confirm the expression 
of different synaptobrevins in 3T3-L1 cells and rat tissues. 
Although we found no significant change in the levels of 
cellubrevin protein following differentiation of 3T3-L1 fi- 
broblasts into adipocytes, there was a significant increase 
in VAMP-2. VAMP-2 expression was also detected in all 
rat tissues that exhibit insulin-regulated glucose transport, 
including white adipose tissue, cardiac, and skeletal muscle 
(Fig. 1). Although the expression of VAMP-2 was highest in 
brain, which is consistent with its role in SSV exocytosis, sig- 
nificant expression of the protein was also evident in most 
other tissues. 
Two other studies have recently demonstrated the pres- 
ence of VAMP-2  (Ralston  et  al.,  1994;  Volchuk  et  al., 
1994, 1995) and ceUubrevin (Volchuk et al., 1994, 1995) in 
insulin-sensitive cell types. It has also been shown that in- 
sulin stimulates the movement of cellubrevin and VAMP-2 
from  intracellular  vesicles  to  the  plasma  membrane  in 
3T3-L1 adipocytes (Volchuk et al., 1995), which is consis- 
tent with the present findings (see Fig. 2). In the study by 
Volchuk et al. (1995) and in a separate study using PC12 
cells (Chilcote et al., 1995; Grote et al.,  1995), it was sug- 
gested that cellubrevin and VAMP-2 are colocalized in the 
same intracellular vesicles, making it difficult to discern 
unique roles for these synaptobrevin homologues. How- 
ever, in view of the similarity in physico-chemical charac- 
teristics of membranes derived from the post-Golgi secre- 
tory/endosomal system  and  because  there  is  a  constant 
flux of membrane through this system, it may be quite dif- 
ficult to identify discrete subcompartments. It is notewor- 
thy that we have been unable to resolve separate intracel- 
lular compartments containing VAMP-2  and cellubrevin 
using a variety of techniques, including vesicle immunoad- 
sorption (see Fig. 4), velocity sedimentation in sucrose, or 
equilibrium  density  sedimentation  in  either  sucrose  or 
glycerol gradients (data not shown). Only by performing 
immuno-EM on intracellular vesicles isolated from rat adi- 
pocytes or by use of the Tf/HRP endosomal ablation tech- 
nique have we been able to show that while there is overlap 
in the intracellular distribution of VAMP-2 and cellubrevin, 
there is also significant intraceUular segregation of these 
two synaptobrevin isoforms. While this conclusion contra- 
dicts recent findings in PC12 cells (Chilcote et al.,  1995; 
Grote et al., 1995), it is conceivable that the segregation of 
these two synaptobrevin isoforms is cell specific. 
It has also been difficult to identify a unique intracellu- 
lar GLUT-4 compartment in insulin-sensitive cells despite 
the  fact  that  such  a  compartment  has  been  postulated 
(Herman et al., 1994; Verhey et al., 1995). A major reason 
for this is because even in the absence of insulin, there is a 
substantial proportion of GLUT-4 in the endosomal sys- 
tem (Slot et al., 1991a,b), presumably because the sorting 
processes that give rise to these vesicles are somewhat in- 
efficient. Similarly, as has been found in the present study 
(see below), low levels of endosomal recycling proteins are 
found in GLUT-4 vesicles, once again presumably due to 
inefficient sorting. These properties have made it difficult 
to segregate these compartments even using specific tech- 
niques such as immunoadsorption with specific antibodies. 
For example, we have previously found that the overall 
polypeptide composition of TfR-containing vesicles and 
GLUT-4-containing vesicles, isolated by immunoadsorp- 
tion with antibodies specific for each protein, is not signifi- 
cantly different (Hanpeter and James, 1995). Thus, in order 
to separate GLUT-4 vesicles from recycling endosomes, 
we have employed two techniques: one which allows us to 
study the protein composition of individual vesicles and 
the other which enables us to remove the bulk of recycling 
endosomes using  an  endocytic marker.  We  believe that 
these  studies  provide reasonable evidence for the  exist- 
ence of an intracellular GLUT-4 compartment in adipo- 
cytes that communicates with the endocytic system. 
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HRP ablation data provide a cohesive view of the intracellu- 
lar distribution of GLUT-4 and other markers in adipocytes. 
The partial but incomplete overlap between GLUT-4 and 
cellubrevin or MPR by immuno-EM was consistent with 
the partial ablation of GLUT-4 compared to these other 
proteins.  Somewhat  surprising  was  the  efficiency with 
which the Tf/HRP conjugate resulted in ablation of the 
MPR (Livingstone et al., 1996) because these two proteins 
are thought to traverse distinct trafficking pathways (Van 
Weert et al., 1995). However, this is not the case in adipo- 
cytes as we have previously shown that immunoadsorption 
of vesicles using a TfR antibody results in efficient coad- 
sorption of the MPR from the LDM fraction isolated from 
these cells (Hanpeter and James, 1995). Regardless, there 
is clearly a  population of intracellular vesicles in adipo- 
cytes that contains as much as 60% of the total GLUT-4 
and relatively little (<10%) of the total amount of MPR, 
cellubrevin, and TfR (Table II). The efficient coisolation 
of cellubrevin-containing vesicles with an antibody specific 
for GLUT-4 (see Fig. 4) was somewhat contradictory to 
this conclusion. This is probably not due to differences in 
cell type used for these two experiments because we also 
observed a significant proportion of GLUT-4 (50%) in vesi- 
cles that did not contain cellubrevin in 3T3-L1 adipocytes 
by immuno-EM (data not shown). We have observed similar 
discrepancies  using the  vesicle  immunoadsorption tech- 
nique to examine the overlap between GLUT-4 and GLUT-1 
in  adipocytes (Piper  et  al.,  1991; Robinson and James, 
1992). We suspect that these discrepancies arise because of 
the considerable heterogeneity in the concentration of dif- 
ferent proteins among different vesicles. In direct support 
of this, the heterogeneity in GLUT-4 labeling among dif- 
ferent vesicles was quite striking (Table  II).  Hence, we 
imagine that the cellubrevin (+ve)/GLUT-4 (-ve) vesicles 
detected by EM may contain very low levels of GLUT-4 
that were sufficient to allow for efficient immunoadsorp- 
tion but that are not detected by EM. It is highly unlikely 
that the heterogeneity in labeling per vesicle is an artifact 
of this technique because it was observed for almost all an- 
tigens tested including GLUT-4, MPR, cellubrevin (Table 
II), and GLUT-1  (data not shown). Hence,  as  suggested 
above, it is likely that this variability represents the nature 
of sorting for membrane proteins in the endosomal sytem. 
We have attempted to determine if there is a correlation 
between GLUT-4 density per vesicle and the presence of 
other markers. However, these analyses have not yet re- 
vealed the biological significance of this observation. 
What is the nature of this separate intracellular com- 
partment of GLUT-4 in adipocytes? It appears to be dis- 
tinct from early and late endosomes as depicted by the ab- 
sence of the TfR, cellubrevin, and MPR (Tables I and II). 
However, these recycling proteins may be present at low 
levels in  this compartment, indicating that this separate 
GLUT-4 compartment is  a  derivative of the endosomal 
system. This is not surprising because kinetic experiments 
using reagents that label GLUT-4 at the cell surface have 
revealed that GLUT-4 constantly recycles both in the ab- 
sence and presence of insulin (Yang and Holman, 1993). 
In doing so, it uses the same pathway as other recycling 
proteins (Robinson et al., 1992; Slot et al., 1991a,b).  This 
postendocytic GLUT-4 compartment is probably not TGR- 
derived  because  TGN38  is  excluded from the  GLUT-4 
compartment (Martin et al., 1994) and relatively low levels 
of GLUT-4 are found in the TGR in adipocytes (Slot et al., 
1991 a,b). In addition, this does not represent newly syn- 
thesized  GLUT-4  because  this compartment persists  in 
cells treated with cycloheximide. This does not exclude the 
possibility of this  being  a  post-TGR  exocytic compart- 
ment. Interestingly, we have recently shown that a  large 
proportion of GLUT-4 is targeted to secretory granules in 
atrial  cardiomyocytes (Slot,  J.W.,  S.  Martin,  and  D.E. 
James, unpublished observation) and that GLUT-4 appar- 
ently joins this compartment at the TGR. 
In VAMP-2, we have identified another protein constit- 
uent of this  compartment which happens  also  to  be  a 
constituent of other regulated secretory compartments in 
a variety of other cell types: SSVs in neurons (Schiavo 
et al., 1992; Stidhof et al., 1993); insulin granules in 13 cells 
(Jo et al.,  1995; Liebenhoff and Rosenthal, 1995);  water 
channel granules that respond to vasopressin (Regazzi et al., 
1995);  and zymogen granules in pancreas  (Braun et al., 
1994). Therefore, it may be predicted that VAMP-2 may 
serve a similar type of specialized function in adipocytes. 
Hence,  cellubrevin  may participate  in  regulating traffic 
through  the  constitutive  recycling  pathway,  whereas 
VAMP-2 may regulate exocytosis of GLUT-4 from a sepa- 
rate storage compartment. However, in this case we would 
have predicted a very large insulin-dependent increase in 
VAMP-2 at the cell surface similar to GLUT-4, but this 
was not evident from the present studies (see Fig. 2).  In 
fact, the effect of insulin on VAMP-2 movement was very 
similar to cellubrevin.  Alternatively, VAMP-2 may play a 
role in facilitating the intracellular sequestration of GLUT-4 
in the absence of insulin and not in the fusion of these ves- 
icles with the cell surface. This may explain why many of 
the VAMP-2 (+ve) vesicles also contain cellubrevin. Fu- 
ture studies will be required to dissect the different roles 
that cellubrevin and VAMP-2 play in the regulated recy- 
cling of GLUT-4. Synaptobrevins are known to bind to 
t-SNAREs, specifically syntaxin (Bennett et al., 1993), and 
so another question is which syntaxins are these synapto- 
brevins binding to in adipocytes? We have only been able 
to identify a single post-Golgi syntaxin isoform in 3T3-L1 
adipocytes, syntaxin 4, which is identical to the rat brain 
isoform (Tellam, J., and D.E. James, unpublished data). 
This  is  of  considerable  interest  as  VAMP-2  has  been 
shown to bind specifically to syntaxin 1A and 4 but not to 
syntaxins 2 or 3 (Calakos et al., 1994). 
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